We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest trading session, McKesson (MCK - Free Report) closed at $508.16, marking a -0.68% move from the previous day. This change lagged the S&P 500's 1.7% gain on the day. On the other hand, the Dow registered a gain of 1.26%, and the technology-centric Nasdaq increased by 2.51%.
The the stock of prescription drug distributor has fallen by 8.35% in the past month, lagging the Medical sector's gain of 1.53% and the S&P 500's gain of 1.27%.
The upcoming earnings release of McKesson will be of great interest to investors. On that day, McKesson is projected to report earnings of $7.11 per share, which would represent year-over-year growth of 14.13%. Our most recent consensus estimate is calling for quarterly revenue of $89.57 billion, up 16% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $32.06 per share and a revenue of $353.29 billion, indicating changes of +16.84% and +14.35%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for McKesson. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.93% higher. As of now, McKesson holds a Zacks Rank of #3 (Hold).
Looking at its valuation, McKesson is holding a Forward P/E ratio of 15.96. This denotes a discount relative to the industry's average Forward P/E of 18.37.
It's also important to note that MCK currently trades at a PEG ratio of 1.19. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Dental Supplies industry currently had an average PEG ratio of 1.89 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 171, positioning it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK - Free Report) closed at $508.16, marking a -0.68% move from the previous day. This change lagged the S&P 500's 1.7% gain on the day. On the other hand, the Dow registered a gain of 1.26%, and the technology-centric Nasdaq increased by 2.51%.
The the stock of prescription drug distributor has fallen by 8.35% in the past month, lagging the Medical sector's gain of 1.53% and the S&P 500's gain of 1.27%.
The upcoming earnings release of McKesson will be of great interest to investors. On that day, McKesson is projected to report earnings of $7.11 per share, which would represent year-over-year growth of 14.13%. Our most recent consensus estimate is calling for quarterly revenue of $89.57 billion, up 16% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $32.06 per share and a revenue of $353.29 billion, indicating changes of +16.84% and +14.35%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for McKesson. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.93% higher. As of now, McKesson holds a Zacks Rank of #3 (Hold).
Looking at its valuation, McKesson is holding a Forward P/E ratio of 15.96. This denotes a discount relative to the industry's average Forward P/E of 18.37.
It's also important to note that MCK currently trades at a PEG ratio of 1.19. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Dental Supplies industry currently had an average PEG ratio of 1.89 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 171, positioning it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.